NURSING CONTINUING EDUCATION

Deprescribing: References

Gnjidic, D., LeCouteur, D. G., Kouladjian, L., & Hilmer, S. N. (2012). Deprescribing trials: Methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clinical Geriatric Medicine, 28(2), 237-253.

Reeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015). A systematic review of the emerging definition of‘deprescribing’ with network analysis: Implications for future research and clinical practice.  British Journal of Clinical Pharmacology, 80(6), 1254-1268. 

Charlesworth, C. J., Smit, E., Lee, D. S., Alramadhan, F., & Odden, M. C. (2015). Polypharmacy among adults ages 65 years and older in the United States.  The Journals of Gerontology: Series A, 70(8),989-995.

Rambhade, S., Chakarborty, A., Shrivastava, A., Patil, U. K., & Rambhade, A. (2012). A survey on polypharmacy and use of inappropriate medications.  Toxicology International, 19(1), 68-73.

Wallis, K. A., Andrews, A., & Henderson, M. (2017). Swimming against the tide: Primary care physicians’ views on deprescribing in everyday practice.  Annals of Family Medicine, 15(4), 341-346.  

Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M. S., & Wiese, M. D. (2013). Patient barriers to and enablers of deprescribing: A systematic review.  Drugs & Aging, 30(10), 793-807. 

Lewis, T. (2004). Using the NO TEARS tool for medication review.  British Medical Journal, 329(4)

Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., & O’Mahony, D. (2008). STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment):Consensus validation.  International Journal of Clinical Pharmacology and Therapeutics, 46(2), 72-83. 

O’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M. N., Ryan, C., & Gallagher, P. (2014).STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2.  Age and Ageing, 44(2), 213-218. 

Reeve, E., Shakib, S., Hendrix, I., Roberts, M.S., & Wiese, M. D. (2014). Review of deprescribingprocesses and development of an evidence-based, patient-centered deprescribing process. British Journal of Clinical Pharmacology, 78(4), 738-747. 

Login to save progress or continue as guest